Malik Fady Ibraham Insider Trades & Stock Holdings

EVP Research & Development · Cytokinetics, Incorporated · Latest filing Oct 6, 2026

Malik Fady Ibraham, EVP Research & Development at Cytokinetics, Incorporated has 4 Form 4 trades on file since Jun 23, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($453.85K), net -$453.85K. Latest filing: disposed of 3.50K shares of $CYTK on Oct 6, 2026 at $61.38.

Trades on file

4

Open-market bought

$0

Open-market sold

$453.85K

Net open-market

-$453.85K

Latest filing

Oct 6, 2026

All insider trades by Malik Fady Ibraham

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 6, 2026	$CYTK	Sell (Open-market sale) 10b5-1	3.50K	$61.38	$214.83K			+0.4%			EVP Research & Development		—
Sep 22, 2026	$CYTK	Sell (Open-market sale) 10b5-1	3.50K	$68.29	$239.01K			-2.9%			EVP Research & Development		—
Jun 23, 2026	$CYTK	Sell (Option exercise)	3.50K	$0	—			+6.5%	+2.4%		EVP Research & Development		—
Jun 23, 2026	$CYTK	Buy (Option exercise)	3.50K	$7.80	$27.30K			+6.5%	+2.4%		EVP Research & Development		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Malik Fady Ibraham traded

• $CYTK

Frequently asked questions

Has Malik Fady Ibraham been buying or selling stock?

Malik Fady Ibraham has 0 open-market purchases and 2 open-market sales on file, net -$453.85K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Malik Fady Ibraham's latest insider trade?

disposed of 3.50K shares of $CYTK on Oct 6, 2026 at $61.38.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.